Literature DB >> 3072462

Reovirus type 1 and type 3 differ in their binding to isolated intestinal epithelial cells.

D B Weiner1, K Girard, W V Williams, T McPhillips, D H Rubin.   

Abstract

Binding of reovirus type 1 to dispersed villus cells from the small intestine was found to be specific for the basolateral membrane. Reovirus type 3 did not bind to any surface of small intestinal epithelial cells, but did bind to intra-epithelial lymphocytes. Using reovirus genetic reassortants, it was shown that the viral attachment polypeptide, encoded by the S1 genome segment of reovirus type 1 is essential for reovirus specific immunofluorescence to villus epithelial cells. In addition, the binding of reovirus type 1 to intestinal cells is saturable. Competition for the binding of 125I-labeled reovirus type 1 was demonstrated with unlabeled reovirus type 1 but not unlabeled reovirus type 3. This indicates that the intestinal epithelial receptor for reovirus is not shared by reovirus serotypes 1 and 3, and infection of intestinal epithelial cells by reovirus type 3 may be limited due to a failure of virus to bind.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072462     DOI: 10.1016/0882-4010(88)90078-2

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.

Authors:  D H Rubin; J D Wetzel; W V Williams; J A Cohen; C Dworkin; T S Dermody
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes.

Authors:  J A Cohen; W V Williams; D B Weiner; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 3.  Strategies for the identification of icosahedral virus receptors.

Authors:  D M Bass; H B Greenberg
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Site of reovirus replication in liver is determined by the type of hepatocellular insult.

Authors:  D H Rubin; A H Morrison; C L Witzleben; C J Guico; D A Piccoli
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.

Authors:  Jason P Fernandes; Francisca Cristi; Heather E Eaton; Patricia Chen; Sarah Haeflinger; Isabelle Bernard; Mary M Hitt; Maya Shmulevitz
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

6.  Selective reovirus infection of murine hepatocarcinoma cells during cell division. A model of viral liver infection.

Authors:  J Taterka; M Sutcliffe; D H Rubin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells.

Authors:  Katherine J D A Excoffon; Kristen M Guglielmi; J Denise Wetzel; Nicholas D Gansemer; Jacquelyn A Campbell; Terence S Dermody; Joseph Zabner
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

8.  Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection.

Authors:  M L Barkon; B L Haller; H W Virgin
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces.

Authors:  Anna Helander; Katherine J Silvey; Nicholas J Mantis; Amy B Hutchings; Kartik Chandran; William T Lucas; Max L Nibert; Marian R Neutra
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 10.  Experimental intestinal reovirus infection of mice: what we know, what we need to know.

Authors:  Dina Montufar-Solis; John R Klein
Journal:  Immunol Res       Date:  2005       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.